Kovitz Investment Group Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$949K Buy
5,072
+2,857
+129% +$525K 0.02% 325
2026
Q1
$418K Hold
2,215
– – 0.01% 414
2025
Q4
$440K Sell
2,215
-1,854
-46% -$375K 0.01% 405
2025
Q3
$826K Buy
4,069
+572
+16% +$101K ﹤0.01% 884
2025
Q2
$615K Buy
3,497
+191
+6% +$28.8K ﹤0.01% 917
2025
Q1
$445K Sell
3,306
-41
-1% -$5.4K ﹤0.01% 936
2024
Q4
$422K Buy
+3,347
New +$498K ﹤0.01% 945

Other funds holding THC

Kovitz Investment Group Partners's THC Position: Q2 2026 in Review

Kovitz Investment Group Partners increased its Tenet Healthcare (THC) stake by 129% in Q2 2026, buying an estimated $525K and bringing the position to 5,072 shares worth $949K. The position accounts for 0.02% of the portfolio, ranked #325.

Kovitz Investment Group Partners first reported a position in THC in Q4 2024 and has held it in 7 quarters since. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Kovitz Investment Group Partners held 5,072 shares of Tenet Healthcare worth $949K as of Q2 2026.
  • Kovitz Investment Group Partners bought 2,857 Tenet Healthcare shares in Q2 2026, an estimated $525K.
  • Tenet Healthcare made up 0.02% of Kovitz Investment Group Partners's portfolio in Q2 2026, its #325 holding.
  • Kovitz Investment Group Partners first reported a position in Tenet Healthcare in Q4 2024 and has held it in 7 quarters since.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q2 2026, filed 12 Aug 2026.